Ignite Creation Date:
2025-12-24 @ 4:59 PM
Ignite Modification Date:
2025-12-31 @ 2:11 PM
Study NCT ID:
NCT07115550
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-08-11
First Post:
2025-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma
Sponsor:
Huai'an First People's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-26
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-08-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08-26
Completion Date Type:
ESTIMATED
First Submit Date:
2025-08-04
First Submit QC Date:
None
Study First Post Date:
2025-08-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-08
Last Update Post Date:
2025-08-11
Last Update Post Date Type:
ACTUAL